Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data ; volume:10 ; number:3 ; day:6 ; month:6 ; year:2023 ; pages:351-356 ; date:9.2023
Drugs - real world outcomes ; 10, Heft 3 (6.6.2023), 351-356, 9.2023
- Creator
-
Garafola, Svetlana
Shiferaw, Elizabeth
Dev, Vikram
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-023-00372-4
- URN
-
urn:nbn:de:101:1-2023112112164968265939
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garafola, Svetlana
- Shiferaw, Elizabeth
- Dev, Vikram
- SpringerLink (Online service)
Other Objects (12)
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study
Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan